Disease Areas
News and analysis on disease research and diagnostics.
Grail Q3 Revenues Grow 39 Percent
Grail reported that strong sales of its blood-based Galleri cancer early detection test drove revenue growth in its first operating quarter as a public company.
Investigators found that they could increase CNS infection diagnoses by using metagenomic next-generation sequencing to test cerebrospinal fluid samples.
Tempus to Offer Cancer Tests Through Flatiron's EMR
The firms said that the deal will provide access to Tempus' testing menu for healthcare providers at 800 cancer care locations that use Flatiron's OncoEMR platform.
Mainz Biomed, Thermo Fisher Scientific to Develop Colorectal Cancer Screening Test
The collaboration will enable Mainz Biomed to harness Thermo Fisher’s resources to develop a new version of its mRNA-based colorectal cancer screening test.
Exagen Q3 Revenues Decline 7 Percent
The firm said its Q3 revenues were negatively impacted by $1.2 million in one-time adjustments.